Bill Snyder

Campus aerials. (John Russell/Vanderbilt University)
October 17, 2012

Beauchamp, Vermund elected to Institute of Medicine

R. Daniel Beauchamp, M.D., chair of the Section of Surgical Sciences, and Sten Vermund, M.D., Ph.D., director of the Vanderbilt Institute for Global Health, have been elected to the Institute of Medicine (IOM), the organization announced this week.

By Bill Snyder
October 15, 2012

VU Neuroscience Graduate Program recognized as best in the nation for 2012

Vanderbilt University’s Neuroscience Graduate Program has been named the 2012 “Program of the Year” by the Society for Neuroscience.

By Bill Snyder
neurons
October 11, 2012

VU scientists cheer Nobel Prize for stem cell research

Vanderbilt University scientists are cheering this year’s Nobel Prize in Medicine for recognizing the discovery that mature cells can be “reprogrammed” into other cell types — a finding which they said has electrified their work.

By Bill Snyder
October 11, 2012

VU recruit’s work lights up genetic ‘dark matter’

They’ve been called “junk DNA” and genetic “dark matter” — the long segments of the human genome (98 percent of it) that do not encode protein.

By Bill Snyder
September 27, 2012

Quantitative and Chemical Biology Program takes shape

The Chemical and Physical Biology Admissions (CPB-A) Program, an inter-departmental first-year graduate admissions program at Vanderbilt University, has been renamed the Quantitative and Chemical Biology (QCB) Program.

By Bill Snyder
September 27, 2012

VU Research Studio Program lauded at AAMC meeting

Vanderbilt University’s Clinical and Translational Research Studio program has won the Award with Distinction for Innovations in Research Training and Education from the Association of American Medical Colleges (AAMC).

By Bill Snyder
September 27, 2012

AAMC meet highlights need for research funds

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.
By Bill Snyder
September 21, 2012

VU, Bristol-Myers to collaborate on Parkinson’s therapies

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson’s disease.
By Bill Snyder
September 20, 2012

Mchaourab to lead Chemical and Physical Biology program

Hassane Mchaourab, Ph.D., professor of Molecular Physiology & Biophysics, Physics and Chemistry, has been named the new director of the Ph.D.-granting Chemical and Physical Biology (CPB) program at Vanderbilt University.
By Bill Snyder
September 20, 2012

VUMC poised to lead as health care reform evolves

Congress has not yet figured out how to reduce the national debt without slashing health care spending and research. How will Vanderbilt University Medical Center respond?
By Bill Snyder
September 14, 2012

Getting Personal

By Bill Snyder
September 13, 2012

Charo set for season’s first Flexner Discovery Lecture

R. Alto Charo, J.D., a nationally known bioethicist at the University of Wisconsin Law School in Madison, will deliver the first Flexner Discovery Lecture on Thursday, Sept. 20.
By Bill Snyder
1 … 106 107 108 109 110 … 112